Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis

Frédéric Medina, Chamaida Plasencia, Philippe Goupille, David Ternant, Alejandro Balsa, Denis Mulleman

Open source

DOI
10.1097/ftd.0000000000000421
Published
2017-08
Container
Therapeutic Drug Monitoring
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/ftd.0000000000000421,
  title = {Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis},
  author = {Frédéric Medina and Chamaida Plasencia and Philippe Goupille and David Ternant and Alejandro Balsa and Denis Mulleman},
  year = {2017},
  journal = {Therapeutic Drug Monitoring},
  doi = {10.1097/ftd.0000000000000421},
  url = {https://doi.org/10.1097/ftd.0000000000000421}
}

RIS

TY  - JOUR
TI  - Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis
AU  - Frédéric Medina
AU  - Chamaida Plasencia
AU  - Philippe Goupille
AU  - David Ternant
AU  - Alejandro Balsa
AU  - Denis Mulleman
PY  - 2017
JO  - Therapeutic Drug Monitoring
DO  - 10.1097/ftd.0000000000000421
UR  - https://doi.org/10.1097/ftd.0000000000000421
ER  - 

APA

Medina, F., Plasencia, C., Goupille, P., Ternant, D., Balsa, A., & Mulleman, D. (2017). Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis. Therapeutic Drug Monitoring. https://doi.org/10.1097/ftd.0000000000000421

Source records